Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of AOAC International"
DOI: 10.5740/jaoacint.16-0295
Abstract: Sofosbuvir (SOFO) was approved by the U.S. Food and Drug Administration in 2013 for the treatment of hepatitis C virus infection with enhanced antiviral potency compared with earlier analogs. Notwithstanding, all current editions of the…
read more here.
Keywords:
determination sofosbuvir;
pharmaceuticals several;
sofosbuvir pharmaceuticals;
determination ... See more keywords